Aminopeptidase activity in human nasal mucosa
Autor: | Kimihiro Ohkubo, Marco Merida, Louis B. Hersh, James N. Baraniuk, Michael A. Kaliner, Robert J. Hohman |
---|---|
Rok vydání: | 1998 |
Předmět: |
Cytosol alanyl aminopeptidase
medicine.medical_specialty Immunology Mucous membrane of nose NEP: Neutral endopeptidase CD13 Antigens Biology Turbinates Aminopeptidases Binding Competitive Aminopeptidase Article ACE: Angiotensin-converting enzyme Substrate Specificity Puromycin-Sensitive Aminopeptidase Leucyl Aminopeptidase rhinitis Leucine Ala-NA: Alanine-p -nitroanilide Internal medicine Enkephalin-degrading aminopeptidase medicine Humans Immunology and Allergy Protease Inhibitors Zymography puromycin sensitive aminopeptidase ApM: Aminopeptidase M Antigens Leucyl aminopeptidase aminopeptidase M Histocytochemistry Ala-MNA: l -alanine-4-methoxy-2-naphthylamide Leu-Ap: Leucine-enkephalin–degrading aminopeptidase Nasal Lavage Fluid Immunohistochemistry PS-Ap: Puromycin-sensitive aminopeptidase Nasal Mucosa Endocrinology glandular secretion Electrophoresis Polyacrylamide Gel Puromycin Alanine aminopeptidase Ala-Ap: Alanine aminopeptidase bradykinin Subcellular Fractions |
Zdroj: | The Journal of Allergy and Clinical Immunology |
ISSN: | 0091-6749 |
DOI: | 10.1016/s0091-6749(98)70013-2 |
Popis: | Background: Aminopeptidases activate bradykinin and degrade many inflammatory peptides. Objective: The objective of this study was to identify the types of aminopeptidase activities in human nasal mucosa. Methods: Human nasal mucosa was homogenized (n = 12), and cytoplasmic (S2) and membrane-rich (P2) fractions were obtained. Several aminopeptidase (Ap) activities were defined by (1) substrate specificity with leucine-enkephalin (leu-Ap) and alanine-nitroanilide (ala-Ap), (2) inhibitor studies with puromycin and bestatin, (3) enzyme activity histochemistry (zymography), (4) immunohistochemistry, and (5) gel electrophoresis. Human volunteers had methacholine, histamine, and allergen nasal provocations to determine the mechanisms controlling nasal aminopeptidase secretion in vivo. Results: P2 was the largest reservoir of puromycin-resistant aminopeptidase activity (630 pmol leu-enk/min/mg protein). S2 contained 32 pmol leu-enk/min/mg activity, with 80% representing puromycin-resistant activity and 20% puromycin-sensitive aminopeptidase (PS-Ap). Ala-Ap was detected in both P2 and S2 fractions and was localized by zymography to epithelial and gland cells. Anti–rat brain–soluble PS-Ap IgG detected immunoreactive material in epithelium, glands, and endothelium. In nasal provocation studies, leu-AP correlated with glandular exocytosis but not vascular leak. Conclusions: The predominant aminopeptidase in human nasal epithelial and submucosal gland cells was membrane-bound puromycin-resistant aminopeptidase. A novel soluble puromycin-resistant aminopeptidase and lower amounts of soluble PS-Ap were also detected. (J Allergy Clin Immunol 1998;102:741-50.) |
Databáze: | OpenAIRE |
Externí odkaz: |